Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C81421
http://purl.obolibrary.org/obo/NCIT_C81421
|
|---|---|
| Preferred Name | Leurubicin |
| Definitions |
An N-L-leucyl prodrug of the anthracycline doxorubicin, with antineoplastic activity. Leurubicin is converted to its active form doxorubicin in or on tumor cells by hydrolytic enzymes.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An N-L-leucyl prodrug of the anthracycline doxorubicin, with antineoplastic activity. Leurubicin is converted to its active form doxorubicin in or on tumor cells by hydrolytic enzymes. |
|---|---|
| prefLabel | Leurubicin
|
| label | Leurubicin
|
| code | C81421
|
| prefixIRI | NCIT:C81421
|
| in_subset | |
| Preferred_Name | Leurubicin
|
| FDA_UNII_Code | 1Z20MGK851
|
| Contributing_Source | FDA
|
| Chemical_Formula | C33H40N2O12
|
| Maps_To | Leurubicin
|
| CAS_Registry | 70774-25-3
|
| Legacy Concept Name | Leurubicin
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C2825623
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |